ARCHIVES

Afinitor Increases Overall Survival To 3.5 Years in Phase III Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 9 | September 26, 2014

Download PDF Visit The Full Archive

Related Articles

Margaret Edwards, 80, Cancer Education Pioneer, Dead

September 16, 1994

In Brief: Susan Braun Named CEO, Komen Foundation; NCCF Research Fellowship Honors Norman

July 12, 1996

House Passes 2.8 Percent Increase For NCI

December 11, 2009

Pollin Prize honors four pioneers in treatment of childhood leukemia.

December 12, 2003

ICF Clement Joins Dynalectron In FCRF

January 9, 1987

Drug Development: Herceptin Associated with 15 Deaths, Genentech Says

May 12, 2000